Steno Diabetes Center Copenhagen — Clinical Trial Site

33 Registered trials

20 Currently recruiting

Organisation

Steno Diabetes Center Copenhagen

Location

Herlev, Denmark

Identifier

ORG-100042276

Address

Borgmester Ib Juuls Vej 83, 2730, Denmark

Departments

Cardiology
Clinical and Translational Research, Complications Research
Clinical Research
Clinical Research, Department of Complications Research
Clinical Translational Research
Complications research
Department of Clinical and Translational Research
Diabetes Center, Complications Research
Diabetes Complications
Komplikationsforskningen
N/A
NA
Nephrology
Steno Diabetes Center Copenhagen
Translational Clinical Research, Paediatrics
Translational Type 2-Diabetes Research
Type 1 Diabetes Outpatient Clinic

Clinical trials at this site (33)

Search interface

A research study to investigate the effects of CagriSema compared to placebo in people with type 2 diabetes and painful diabetic peripheral … Ended

2023-509662-38-00 Type 2 diabetes and painful diabetic peripheral neuropa 4 2025-01-22
A trial to learn how well baxdrostat with dapagliflozin works compared to dapagliflozin alone and how safe it is in adults with chronic kidn… Ended

2023-506457-38-00 Chronic kidney disease (CKD) and hypertension. 5 2024-06-05
CAT-Trial: CGRP monoclonal Antibody for Treatment of painful diabetic neuropathy: a double-blind, multicenter, placebo-controlled, internati… Ended

2022-500338-27-00 Painful diabetic polyneuropathy 4 2023-09-14
Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controll… Ended

2022-502038-23-00 Type 1 diabetes 4 2023-08-25
A study to learn how well the study treatment finerenone works and how safe it is in people with long-term decrease in the kidneys’ ability … Ended

2022-503024-27-00 Chronic kidney disease associated with type 1 diabetes 5 2024-02-27
REIMAGINE 2: A research study to see how well CagriSema compared to semaglutide, cagrilintide and placebo lowers blood sugar and body weight… Ended

2022-502678-18-00 Type 2 diabetes 5 2023-11-07
Effects of empagliflozin on plasma glucose in patients with HNF1A-MODY: a randomized, double-blind, crossover trial Ended

2023-503760-17-00 Maturity-onset diabetes of the young type 3 (HNF1A-MODY 4 2023-10-11
The RADIAL study: A clinical trial to learn more about the benefits and the acceptability of trials that include technology to centre the tr… Ended

2022-500449-26-00 Type 2 diabetes mellitus (T2DM) 6 2023-08-03
A study to learn how well the treatment combination of finerenone and empagliflozin works and how safe it is compared to each treatment alon… Ended

2023-506981-30-00 Chronic kidney disease in type 2 diabetes mellitus 4 2022-05-25